Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors
Authors
Keywords
microRNA, miR-34a, Experimental therapeutics, Phase I trial, Advanced solid tumors
Journal
INVESTIGATIONAL NEW DRUGS
Volume 35, Issue 2, Pages 180-188
Publisher
Springer Nature
Online
2016-12-05
DOI
10.1007/s10637-016-0407-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epigenetic Modulators and the New Immunotherapies
- (2016) Anthony E. Dear NEW ENGLAND JOURNAL OF MEDICINE
- Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses
- (2015) Katherine B. Chiappinelli et al. CELL
- Tumor suppressor miR-34a targets PD-L1 and functions as a potential immunotherapeutic target in acute myeloid leukemia
- (2015) Xi Wang et al. CELLULAR SIGNALLING
- Immune Checkpoint Blockade in Cancer Therapy
- (2015) Michael A. Postow et al. JOURNAL OF CLINICAL ONCOLOGY
- PDL1 Regulation by p53 via miR-34
- (2015) Maria Angelica Cortez et al. JNCI-Journal of the National Cancer Institute
- Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- and tissue-specific microRNAs
- (2015) Eric Londin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PDL1 Regulation by p53 via miR-34
- (2015) Maria Angelica Cortez et al. JNCI-Journal of the National Cancer Institute
- In Vivo Delivery of miR-34a Sensitizes Lung Tumors to Radiation Through RAD51 Regulation
- (2015) Maria Angelica Cortez et al. Molecular Therapy-Nucleic Acids
- Increased MicroRNA-34b and -34c Predominantly Expressed in Stromal Tissues Is Associated with Poor Prognosis in Human Colon Cancer
- (2015) Yukiharu Hiyoshi et al. PLoS One
- Quantification of Therapeutic miRNA Mimics in Whole Blood from Nonhuman Primates
- (2014) Kevin Kelnar et al. ANALYTICAL CHEMISTRY
- dsRNA-Activation of TLR3 and RLR Signaling: Gene Induction-Dependent and Independent Effects
- (2014) Saurabh Chattopadhyay et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Systemic Delivery of a miR34a Mimic as a Potential Therapeutic for Liver Cancer
- (2014) C. L. Daige et al. MOLECULAR CANCER THERAPEUTICS
- A phase 1 study of the BCL2-targeted deoxyribonucleic acid inhibitor (DNAi) PNT2258 in patients with advanced solid tumors
- (2013) Anthony W. Tolcher et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- MicroRNA-34a Enhances T Cell Activation by Targeting Diacylglycerol Kinase ζ
- (2013) Jinwook Shin et al. PLoS One
- Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: In Vitro and In Vivo Evidence
- (2012) M. T. Di Martino et al. CLINICAL CANCER RESEARCH
- Systemic microRNA-34a delivery induces apoptosis and abrogates growth of diffuse large B-cell lymphoma in vivo
- (2012) V J Craig et al. LEUKEMIA
- MicroRNA and cancer
- (2012) Martin D. Jansson et al. Molecular Oncology
- miR-34 – a microRNA replacement therapy is headed to the clinic
- (2012) Andreas G. Bader Frontiers in Genetics
- Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: Prediction and prevention
- (2011) Janos Szebeni et al. ADVANCED DRUG DELIVERY REVIEWS
- MicroRNA Molecular Profiles Associated with Diagnosis, Clinicopathologic Criteria, and Overall Survival in Patients with Resectable Pancreatic Ductal Adenocarcinoma
- (2011) N. B. Jamieson et al. CLINICAL CANCER RESEARCH
- Developing therapeutic microRNAs for cancer
- (2011) A G Bader et al. GENE THERAPY
- miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy
- (2011) Fumihiko Nakatani et al. JOURNAL OF PATHOLOGY
- Systemic Delivery of Tumor Suppressor microRNA Mimics Using a Neutral Lipid Emulsion Inhibits Lung Tumors in Mice
- (2011) Phong Trang et al. MOLECULAR THERAPY
- The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
- (2011) Can Liu et al. NATURE MEDICINE
- The Promise of MicroRNA Replacement Therapy
- (2010) A. G. Bader et al. CANCER RESEARCH
- Development of a Lung Cancer Therapeutic Based on the Tumor Suppressor MicroRNA-34
- (2010) J. F. Wiggins et al. CANCER RESEARCH
- miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions
- (2010) Zandra Hagman et al. INTERNATIONAL JOURNAL OF CANCER
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- The miR-34 family in cancer and apoptosis
- (2009) H Hermeking CELL DEATH AND DIFFERENTIATION
- MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-Initiating Cells
- (2009) Qing Ji et al. PLoS One
- MicroRNA Profiling of BRCA1/2 Mutation-Carrying and Non-Mutation-Carrying High-Grade Serous Carcinomas of Ovary
- (2009) Cheng-Han Lee et al. PLoS One
- miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells
- (2008) Na Li et al. CANCER LETTERS
- Misinterpreting the Therapeutic Effects of Small Interfering RNA Caused by Immune Stimulation
- (2008) Marjorie Robbins et al. HUMAN GENE THERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started